Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Raphael Mohr

Showing results (21-30 of 75) with videos related to

Pageof 8
Sort By:
Journal of Cancer Research and Clinical Oncology|June 15, 2023
Osteopontin is a prognostic circulating biomarker in patients with neuroendocrine neoplasmsEvelyn Kidess, Yvonne Giesecke, Ines Eichhorn, et al.
Journal of Cancer Research and Clinical Oncology|July 6, 2023
Prevalence of and factors associated with a treatment delay due to the COVID-19 pandemic in patients with gastrointestinal cancer in EuropeChristoph Roderburg, Sven H Loosen, Catherine Leyh, et al.
Journal for Immunotherapy of Cancer|September 23, 2025
HLA-A*01:01-B*08:01-C*07:01 is linked to early-onset immune checkpoint inhibitor-induced myositis and myocarditisLeonie Müller-Jensen, Lukas Flatz, Omar Hasan Ali, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|July 6, 2023
Non-Alcoholic Fatty Liver Disease (NAFLD) and risk of new-onset heart failure: a retrospective analysis of 173,966 patientsChristoph Roderburg, Sarah Krieg, Andreas Krieg, et al.
Medicine|April 29, 2018
Return-to-health effect of modern combined antiretroviral therapy potentially predisposes HIV patients to hepatic steatosisRaphael Mohr, Christoph Boesecke, Leona Dold, et al.
Frontiers in Immunology|April 16, 2021
Lessons From Immune Checkpoint Inhibitor Trials in Hepatocellular CarcinomaRaphael Mohr, Fabian Jost-Brinkmann, Burcin Özdirik, et al.
Wound Repair and Regeneration : Official Publication of the Wound Healing Society [And] the European Tissue Repair Society|June 15, 2005
Treatment of deep sternal wound infections post-open heart surgery by application of activated macrophage suspensionArie Orenstein, Erez Kachel, Adi Zuloff-Shani, et al.
Cancers|May 13, 2023
Interventional Treatment Strategies in Intrahepatic Cholangiocarcinoma and Perspectives for Combined Hepatocellular-CholangiocarcinomaTimo Alexander Auer, Federico Collettini, Laura Segger, et al.
European Radiology|April 28, 2023
Gd-EOB MRI for HCC subtype differentiation in a western population according to the 5<sup>th</sup> edition of the World Health Organization classificationTimo A Auer, Sebastian Halskov, Uli Fehrenbach, et al.
European Radiology Experimental|February 14, 2025
CT-guided high-dose-rate brachytherapy ablation of HCC patients with portal vein tumor thrombosisTimo Alexander Auer, Marie-Luise Helene Hildegard Ranner-Hafferl, Melina Anhamm, et al.
Pageof 8

Showing results (21-30 of 75) with videos related to

Sort By:
Pageof 8
Journal of Cancer Research and Clinical Oncology|June 15, 2023
Osteopontin is a prognostic circulating biomarker in patients with neuroendocrine neoplasmsEvelyn Kidess, Yvonne Giesecke, Ines Eichhorn, et al.
Journal of Cancer Research and Clinical Oncology|July 6, 2023
Prevalence of and factors associated with a treatment delay due to the COVID-19 pandemic in patients with gastrointestinal cancer in EuropeChristoph Roderburg, Sven H Loosen, Catherine Leyh, et al.
Journal for Immunotherapy of Cancer|September 23, 2025
HLA-A*01:01-B*08:01-C*07:01 is linked to early-onset immune checkpoint inhibitor-induced myositis and myocarditisLeonie Müller-Jensen, Lukas Flatz, Omar Hasan Ali, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|July 6, 2023
Non-Alcoholic Fatty Liver Disease (NAFLD) and risk of new-onset heart failure: a retrospective analysis of 173,966 patientsChristoph Roderburg, Sarah Krieg, Andreas Krieg, et al.
Medicine|April 29, 2018
Return-to-health effect of modern combined antiretroviral therapy potentially predisposes HIV patients to hepatic steatosisRaphael Mohr, Christoph Boesecke, Leona Dold, et al.
Frontiers in Immunology|April 16, 2021
Lessons From Immune Checkpoint Inhibitor Trials in Hepatocellular CarcinomaRaphael Mohr, Fabian Jost-Brinkmann, Burcin Özdirik, et al.
Wound Repair and Regeneration : Official Publication of the Wound Healing Society [And] the European Tissue Repair Society|June 15, 2005
Treatment of deep sternal wound infections post-open heart surgery by application of activated macrophage suspensionArie Orenstein, Erez Kachel, Adi Zuloff-Shani, et al.
Cancers|May 13, 2023
Interventional Treatment Strategies in Intrahepatic Cholangiocarcinoma and Perspectives for Combined Hepatocellular-CholangiocarcinomaTimo Alexander Auer, Federico Collettini, Laura Segger, et al.
European Radiology|April 28, 2023
Gd-EOB MRI for HCC subtype differentiation in a western population according to the 5<sup>th</sup> edition of the World Health Organization classificationTimo A Auer, Sebastian Halskov, Uli Fehrenbach, et al.
European Radiology Experimental|February 14, 2025
CT-guided high-dose-rate brachytherapy ablation of HCC patients with portal vein tumor thrombosisTimo Alexander Auer, Marie-Luise Helene Hildegard Ranner-Hafferl, Melina Anhamm, et al.
Pageof 8